Howard W. Robin
2018
In 2018, Howard W. Robin earned a total compensation of $13.3M as President and Chief Executive Officer at Nektar Therapeutics, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,647,100 |
|---|---|
| Option Awards | $5,618,256 |
| Salary | $968,921 |
| Stock Awards | $4,998,206 |
| Other | $98,184 |
| Total | $13,330,667 |
Robin received $5.6M in option awards, accounting for 42% of the total pay in 2018.
Robin also received $1.6M in non-equity incentive plan, $968.9K in salary, $5M in stock awards and $98.2K in other compensation.
Rankings
In 2018, Howard W. Robin's compensation ranked 415th out of 14,244 executives tracked by ExecPay. In other words, Robin earned more than 97.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 415 out of 14,244 | 97th |
Division Manufacturing | 146 out of 5,765 | 98th |
Major group Chemicals And Allied Products | 44 out of 2,128 | 98th |
Industry group Drugs | 35 out of 1,817 | 98th |
Industry Pharmaceutical Preparations | 24 out of 1,391 | 98th |
Source: SEC filing on April 30, 2019.
Robin's colleagues
We found four more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2018.
2018
Jillian Thomsen
Nektar Therapeutics
Chief Accounting Officer
2018
Gil Labrucherie
Nektar Therapeutics
Chief Financial Officer
2018
Stephen Doberstein
Nektar Therapeutics
Chief Research and Development Officer
2018
Maninder Hora
Nektar Therapeutics